Nath Bio-Genes (India) Limited (NATHBIOGEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.09 Billion ≈ $-11.75 Million USD) by net assets (Rs6.80 Billion ≈ $73.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NATHBIOGEN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Nath Bio-Genes (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2026)
This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corentec Co Ltd
KQ:104540
|
0.100x |
|
SJM Co Ltd
KO:123700
|
0.046x |
|
Hammer Metals Ltd
AU:HMX
|
-0.019x |
|
Q linea AB
ST:QLINEA
|
-0.099x |
|
RS GROUP PLC
LSE:RS1
|
0.087x |
|
Wiseway Group Ltd
AU:WWG
|
0.102x |
|
Rossmax International Ltd
TWO:4121
|
0.044x |
|
WINSON Machinery Co Ltd
TWO:4538
|
0.020x |
Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2026)
The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. For the full company profile with market capitalisation and key ratios, see NATHBIOGEN market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs6.80 Billion ≈ $73.59 Million |
Rs-220.35 Million ≈ $-2.38 Million |
-0.032x | -218.69% |
| 2025-03-31 | Rs6.44 Billion ≈ $69.69 Million |
Rs175.81 Million ≈ $1.90 Million |
0.027x | -72.93% |
| 2024-03-31 | Rs6.10 Billion ≈ $65.96 Million |
Rs614.80 Million ≈ $6.65 Million |
0.101x | +50.59% |
| 2023-03-31 | Rs5.73 Billion ≈ $61.99 Million |
Rs383.67 Million ≈ $4.15 Million |
0.067x | +112.82% |
| 2022-03-31 | Rs5.42 Billion ≈ $58.61 Million |
Rs170.46 Million ≈ $1.84 Million |
0.031x | +1633.30% |
| 2021-03-31 | Rs6.13 Billion ≈ $66.32 Million |
Rs11.13 Million ≈ $120.35K |
0.002x | -89.32% |
| 2020-03-31 | Rs5.58 Billion ≈ $60.30 Million |
Rs94.74 Million ≈ $1.02 Million |
0.017x | +139.22% |
| 2019-03-31 | Rs5.08 Billion ≈ $54.89 Million |
Rs-219.89 Million ≈ $-2.38 Million |
-0.043x | +56.74% |
| 2018-03-31 | Rs4.69 Billion ≈ $50.75 Million |
Rs-469.84 Million ≈ $-5.08 Million |
-0.100x | -512.04% |
| 2017-03-31 | Rs1.38 Billion ≈ $14.88 Million |
Rs33.43 Million ≈ $361.58K |
0.024x | +120.81% |
| 2016-03-31 | Rs1.21 Billion ≈ $13.12 Million |
Rs-141.68 Million ≈ $-1.53 Million |
-0.117x | -285.23% |
| 2015-03-31 | Rs1.07 Billion ≈ $11.59 Million |
Rs67.55 Million ≈ $730.58K |
0.063x | -65.69% |
| 2014-03-31 | Rs817.78 Million ≈ $8.84 Million |
Rs150.28 Million ≈ $1.63 Million |
0.184x | -25.68% |
| 2013-03-31 | Rs574.74 Million ≈ $6.22 Million |
Rs142.11 Million ≈ $1.54 Million |
0.247x | -- |
About Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jow… Read more